Skip to content

Public FDA record

Z-0164-2015: Siemens Calibrator E; SMN 10309079 (2 pack), SMN 10321075 (6 pack), SMN 10335532 (6 pack Ref)

Recall record Z-0164-2015 for Siemens Healthcare Diagnostics, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0164-2015
Company in FDA record
Siemens Healthcare Diagnostics, Inc
FDA classification date
Dec 16, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Positive bias for Calibrator E lot kits ending in 38 and 39 with the ADVIA Centaur Systems Cortisol and Progesterone assays compared to the respective master curves.

Source facts

Action
An Urgent Medical Device Correction (UMDC) was sent to all affected Siemens Healthcare Diagnostics customers in the United States on September 26, 2014. An Urgent Field Safety Notice (UFSN) was sent out for distribution to all customers outside the United States on September 26, 2014. These notices inform the customer of the positive bias with ADVIA Centaur Systems Cortisol and Progesterone when calibrated with Calibrator E kit lots ending in 38 and 39.Customers may continue use of the affected lots as the clinical utility of the assay is not impacted. The communications also provide information on the performance of the assays when they use Calibrator E kit lots ending in 40. The notices should be reviewed with the facility's laboratory or Medical director. All affected domestic customers were sent a hard copy of the Urgent Medical Device Correction via Federal Express. Fax-back forms will be used to confirm that the customers received the UMDC. For those customers that do not return a fax-back form, a Siemens representative will follow up with those customers to ensure they received the Urgent Medical Device Correction and completed the required actions. All affected customers outside the US will be provided a copy of the Urgent Field Safety Notice via hard copy, e-mail, and/or fax as determined by each country's local regulations and procedures. Each customer will be required to return a completed confirmation fax-back to Siemens. For those customers that do not return a fax-back form, a Siemens representative will follow up with those customers to ensure they received the Urgent Field Safety Notice and completed the required actions.
Initiated
2014-09-26
Root cause
Device Design
Terminated
2016-01-29
Distribution
Nationwide including Puerto Rico. Worldwide: Afghanistan, Armenia, Austria, Bahrain, Belgium, Bulgaria, Burkina Faso, Canary Islands, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Great Britain, Greece, Hungary, Iran, Iraq, Ireland, Italy, Jordan, Kazakhstan, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Macedonia, Malta, Morocco, Netherlands, Norway, Oman, Pakistan, Poland, Portugal, Qatar, Romania, Russian Fed., Saudi Arabia, Serbia, Slovakia, Spain, Sweden, Switzerland, Turkey, Unit.Arab Emir., Vatican, Yemen, AR, AU, BD, BR, CA , CH, CL, CN, CO, DO, EC, EG, GT, HK, ID, IE, IL, IN, JP, KR, LY, MM, MX, MY, NI, NP, NZ, PE, PH, PY, SA, SG, SV, TH, TW, UY, VN, ZA
Recall number
Z-0164-2015
Recall status
Terminated
CDRH record ID
130527
FDA classified
2014-12-16
Recall event number
69430

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗